Amostar Tablet 40/5 mg

Adult dose

The recommended dose of this medication is one tablet once daily, to be taken with water regardless of meals. It is advisable to take it at the same time every day (e.g., in the morning). In patients with renal impairment, no dosage adjustment is needed for mild to moderate renal impairment, but patients with severe renal impairment should start at a lower dose and increase it gradually. Patients with liver impairment should have a telmisartan daily dosage not exceeding 40 milligrams.

Child dose

Safety and efficacy for pediatric patients under 18 years of age have not been established, therefore the use of this medication is not recommended.

This medication should not be used during pregnancy, especially in the second and third trimesters, as it may pose serious risks to the fetus. It should be discontinued as soon as pregnancy is confirmed. This medication should not be administered to patients with allergies to specific components, severe liver dysfunction, severe hypotension, or serious heart-related diseases. Additionally, this drug should not be used in pregnant or nursing women or patients with biliary obstructive disease. Patients with primary aldosteronism or specific heart valve diseases should use this medication cautiously, and patients with liver impairment may require dosage adjustments and close monitoring. Patients with gastrointestinal diseases, renal artery hypertension, renal failure, and elderly patients should use this medication with special caution. Common side effects can include dizziness and peripheral edema, with serious side effects occurring rarely. Symptoms of hypotension may present; appropriate measures are necessary when such symptoms occur. There is a risk of elevated potassium levels in the blood, so potassium levels should be checked regularly, and caution is necessary when used in conjunction with potassium-containing medications. Patients with heart diseases should use this medication cautiously as it may increase the risk of angina or myocardial infarction. This medication may cause drowsiness or dizziness; caution is needed when driving or operating hazardous machinery. This medication may interact with other specific drugs; if there are co-administered medications, it is crucial to consult with a doctor or pharmacist. Pregnant or nursing women should avoid using this medication, and especially during breastfeeding, it is safest not to use this medication. The safety and efficacy of this drug in pediatric patients have not been established, thus its use is not recommended. Elderly patients may be more sensitive to this medication, requiring careful dosage adjustments. In cases of overdose, symptoms such as hypotension, dizziness, and heart issues may occur, necessitating immediate medical assistance. This medication should be kept out of reach of children, and it is advisable not to change the packaging for storage. The packaging should not be opened until just before administration to maintain the quality of the drug.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reaction, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, severe skin adverse reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory distress accompanied by cough and fever, jaundice (yellowing of skin or eyes), profound lethargy, liver abnormalities (jaundice), sudden and severe headache.

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory infection
• urinary tract infection
• anemia
• hyperkalemia
• depression
• insomnia
• drowsiness
• headache

This medication should be stored in a tightly sealed container that protects from light, in a temperature range of 1 to 30 degrees Celsius. Storing it this way helps maintain its efficacy and safety.

Appearance

A white and light gray, double convex, oval-shaped tablet.

Package unit

30 tablets (10 tablets/PTP x 3)